Circle Pharma
PrivateLast Round
Series D
Sep 3, 2024
Total Funding Raised
$207.5M
Company Overview
Circle Pharma is a biopharmaceutical company specializing in the development of macrocycle therapeutics aimed at targeting previously undruggable proteins for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circle Pharma Comps
Public and private peers based on sector, stage, and business model.
Circle Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 3, 2024 | ||||
| Series C | Jun 16, 2021 | ||||
| Series B | Mar 17, 2020 | ||||
| Series A | Apr 25, 2017 | ||||
| Seed | Jan 7, 2016 | ||||
Seed | Sep 22, 2014 |
Key People
Founding team and executive leadership
Circle Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series C, Series D |
| WI Harper Group | Series A |
| Lifeforce Capital | Series B, Series C, Series A |
| The Chernin Group | Series B, Series C |
| Hartford Hospital | Series C |
| Element Partners | Series A |
| Nextech Invest | Series B, Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2026
CEO to present at the J.P. Morgan Healthcare Conference on Jan 14, 2026.
- Dec 1, 2025
Anne E. Borgman, M.D. appointed as new CMO.
Circle Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Circle Pharma's valuation, stock price, and market status.